Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Guinan

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Current Therapeutic Research, Clinical and Experimental|November 1, 1976
"Immunostaging" of patients with prostatic cancer: correlation of "immunostage" and clinical stage. An interim reportR J Ablin, P D Guinan, B Sundar, et al.
Clinical and Experimental Immunology|October 1, 1979
Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancerR J Ablin, R A Bhatti, P D Guinan, et al.
Journal of Surgical Oncology|October 1, 1991
Cytoreductive surgery impedes metastasis and enhances the immune response: a preliminary reportG Grinis, P Targonski, M Shaw, et al.
Surgery, Gynecology & Obstetrics|January 1, 1972
The bacteriology of ileal conduit urine in manP D Guinan, R H Moore, E Neter, et al.
Allergologia Et Immunopathologia|November 1, 1975
Inhibition of leukocyte migration by serum from patients with prostatic cancerR J Ablin, P D Guinan, I M Bush, et al.
Journal of Reproductive Immunology|February 1, 1980
Effect of human seminal plasma on tumour-associated immunity in patients with adenocarcinoma of the prostateR J Ablin, R A Bhatti, I M Bush, et al.
European Urology|January 1, 1980
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancerR J Ablin, R A Bhatti, I M Bush, et al.
American Journal of Clinical Oncology|February 1, 1982
Adjuvant immunotherapy (BCG) in stage D prostate cancerP D Guinan, T John, G Baumgartner, et al.
European Journal of Cancer|July 1, 1977
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factorR J Ablin, R A Bhatti, G R Bruns, et al.
Lancet (London, England)|August 17, 1974
Letter: Afferent blockage, oestrogenic therapy, and malignancyR J Ablin, G R Bruns, P D Guinan, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Current Therapeutic Research, Clinical and Experimental|November 1, 1976
"Immunostaging" of patients with prostatic cancer: correlation of "immunostage" and clinical stage. An interim reportR J Ablin, P D Guinan, B Sundar, et al.
Clinical and Experimental Immunology|October 1, 1979
Modulatory effects of oestrogen on immunological responsiveness. II. Suppression of tumour-associated immunity in patients with prostatic cancerR J Ablin, R A Bhatti, P D Guinan, et al.
Journal of Surgical Oncology|October 1, 1991
Cytoreductive surgery impedes metastasis and enhances the immune response: a preliminary reportG Grinis, P Targonski, M Shaw, et al.
Surgery, Gynecology & Obstetrics|January 1, 1972
The bacteriology of ileal conduit urine in manP D Guinan, R H Moore, E Neter, et al.
Allergologia Et Immunopathologia|November 1, 1975
Inhibition of leukocyte migration by serum from patients with prostatic cancerR J Ablin, P D Guinan, I M Bush, et al.
Journal of Reproductive Immunology|February 1, 1980
Effect of human seminal plasma on tumour-associated immunity in patients with adenocarcinoma of the prostateR J Ablin, R A Bhatti, I M Bush, et al.
European Urology|January 1, 1980
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancerR J Ablin, R A Bhatti, I M Bush, et al.
American Journal of Clinical Oncology|February 1, 1982
Adjuvant immunotherapy (BCG) in stage D prostate cancerP D Guinan, T John, G Baumgartner, et al.
European Journal of Cancer|July 1, 1977
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factorR J Ablin, R A Bhatti, G R Bruns, et al.
Lancet (London, England)|August 17, 1974
Letter: Afferent blockage, oestrogenic therapy, and malignancyR J Ablin, G R Bruns, P D Guinan, et al.
Pageof 8